Role of antimicrobial peptides in host defense against mycobacterial infections

Peptides

Volumn 29, Issue 10, 2008, Pages 1836-1841

  Méndez Samperio, Patricia ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Antimicrobial peptides; Innate immunity; Mycobacteria; Tuberculosis

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIBACTERIAL ACTIVITY; DRUG MECHANISM; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DEFENSINS; HUMANS; MYCOBACTERIUM INFECTIONS; TUBERCULOSIS;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 52049122588     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.05.024     Document Type: Review

References (76)

1. Ashitani J., Mukae I., Hiratsuka T., Nakazato M., Kumamoto K., and Matsakura S. Elevated levels of α-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest 121 (2002) 519-526
2. Ashitani J., Mukae H., Hiratsuka T., Nakazato M., Kumamoto K., and Matsukura S. Plasma and BAL fluid concentrations of antimicrobial peptides in patients with Mycobacterium avium-intracellulare infection. Chest 119 (2001) 1131-1137
3. Ashitani J., Mukae H., Arimura Y., Tokojima M., and Nakazato M. High concentrations of α-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Life Sci 75 (2004) 1123-1134
4. Bals R., Wang X., Zasloff M., and Wilson J.M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 95 (1998) 9541-9546
5. Bals R. Epithelial peptides in host defense against infection. Respir Res 1 (2000) 141-150
6. Bassler B.L., and Losick R. Bacterially speaking. Cell 125 (2006) 237-246
7. Becker M., Diamond G., Verghese M., and Randell S.H. CD 14-dependent LPS-induced β-defensin expression in human tracheobronchial epithelium. J Biol Chem 275 (2000) 29731-29736
8. Bensch K., Raida M., Magert H.-J., Schulz-Knappe P., and Forssmann W.G. HBD-1: a novel b-defensin from human plasma. FEBS Lett 368 (1995) 331-335
9. Birchler T., Seibl R., Buchner K., Loeliger S., Seger R., Hossle J.P., et al. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur J Immunol 31 (2001) 3131-3137
10. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13 (1995) 61-92
11. Chaly Y.V., Paleolog E.M., Kolesnikova T.S., Tikhonov I., Petratchenko E.V., and Voitenok N. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur Cytokine Netw 11 (2000) 257-266
12. Daher K.A., Lehrer R.I., Ganz T., and Kronenberg M. Isolation and characterization of human defensin cDNA clones. Proc Natl Acad Sci USA 85 (1988) 7327-7331
13. Diamond G., Zasloff M., Eck H., Brasseur M., Maloy W.L., and Bevins C.L. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci USA 88 (1991) 3952-3956
14. Fattorini L., Gennaro R., Zanetti M., Tan D., Brunori L., Giannoni F., et al. In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis. Peptides 25 (2004) 1075-1077
15. Fattorini L., Iona E., Ricci M.L., Thoresen O.F., Orru G., Oggioni M.R., et al. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. Microb Drug Resist 5 (1999) 265-270
16. Fattorini L., Tan D., Iona E., Mattei M., Giannoni F., Brunori L., et al. Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice. Antimicrob Agents Chemother 47 (2003) 360-362
17. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu Rev Immunol 19 (2001) 93-129
18. Furin J. The clinical management of drug-resistant tuberculosis. Curr Opin Pulm Med 13 (2007) 212-217
19. Ganz T., and Lehrer R.I. Defensins. Pharmacol Ther 66 (1995) 191-205
20. Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest 109 (2002) 693-697
21. Ganz T., and Lehrer R.I. Defensins. Curr Opin Immunol 6 (1994) 584-589
22. Ganz T. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun 55 (1987) 568-571
23. Ganz T. Defensins: antimicrobial peptides of innate immunity. Immunology 3 (2003) 710-720
24. Ganz T., Selsted M.E., Szklarek D., Harwig S., Daher K., Bainton D., et al. Defensins: natural peptide antibiotics of human neutrophils. J Clin Invest 76 (1985) 1427-1444
25. García J.-R., Krause A., Schulz S., Rodriguez-Jimenez F.J., Kluver E., Aderman K., et al. Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 10 (2001) 1819-1821
26. Gera J.F., and Lichtenstein A. Human neutrophil peptide defensins induce single strand DNA breaks in target cells. Cell Immunol 138 (1991) 108-120
27. Goldman M.J., Anderson G.M., Stolzenberg E.D., Kari U.P., and Zassloff M. Human β-defensin-1 is a salt-sensitive antibiotic in the lung that is inactivated in cystic fibrosis. Cell 88 (1997) 553-560
28. Hancock R.E.W. Peptide antibiotics. Lancet 349 (1997) 418-422
29. Harder J., Bartels J., Christophers E., and Schröder J.M. A peptide antibiotic from human skin. Nature 387 (1997) 861
30. Harder J., Meyer-hoffert U., and Teran L.M. Mucoid Pseudomonas aeruginosa, TNFα, and IL1β, but not IL-6 induce HBD-2 in respiratory epithelia. Cell Mol Biol Res 22 (2000) 714-721
31. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276 (2001) 5707-5713
32. Hoover D.M., Rajashankar K.R., Blumenthal R., Puri A., Oppenheim J., Chertov O., et al. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J Biol Chem 42 (2000) 32911-32918
33. Jones D.E., and Bevins C.L. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett 315 (1993) 187-192
34. Kao C.Y., Chen Y., Zhao Y.H., and Wu R. ORFeome-based search of airway epithelial cell-specific novel human [beta]-defensin genes. Am J Respir Cell Mol Biol 29 (2003) 71-80
35. Kisich K.O., Higgins M., Diamond G., and Heifets L. Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils. Infect Immun 70 (2002) 4591-4599
36. Kisich K., Heifets L., Higgins M., and Diamond G. Antimycobacterial agent based on mRNA encoding human β-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis. Infect Immun 69 (2001) 2692-2699
37. Larrick J.W., Hirata M., Balint R.F., Lee J., Zhong J., and Wright S.C. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 63 (1995) 1291-1297
38. Lehrer R.I., Barton A., Daher K.A., Harwig S., Ganz T., and Selsted M.E. Interaction of human defensins with Escherichia coli: mechanism of bactericidal activity. J Clin Invest 84 (1989) 553-561
39. Lehrer R., Lichtenstein A., and Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11 (1993) 105-128
40. Lillard Jr. J.W., Boyaka P.N., Chertov O., Oppenheim J.J., and McGhee J.R. Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc Natl Acad Sci USA 96 (1999) 651-656
41. Linzmeier R., Michaelson D., Liu L., and Ganz T. The structure of neutrophil defensin genes. FEBS Lett 321 (1993) 267-273
42. Méndez-Samperio P., Miranda E., and Trejo A. Mycobacterium bovis Bacillus Calmette-Guérin (BCG) stimulates human beta-defensin-2 gene transcription in human epithelial cells. Cell Immunol 239 (2006) 61-66
43. Méndez-Samperio P., Alba L., and Belmont L. Chemokines and mycobacterial infection: critical roles of the TLRs, and their signaling pathways. In: Leah R., and Grinwald (Eds). Chemokine research trends (2007), Nova Science Publishers, Inc. 7-28 [Chapter 1]
44. Méndez-Samperio P., Alba L., and Trejo A. Mycobacterium bovis-mediated induction of human beta-defensin-2 in epithelial cells is controlled by intracellular calcium and p38MAPK. J Infect 54 (2007) 469-474
45. Miyakawa Y., Ratnakar P., Rao A.G., Costello M.L., Mathieu-Costello O., Lehrer R.I., et al. In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun 64 (1996) 926-932
46. Nuermberger E., Rosenthal I., Tyagi S., Williams K.N., Almeida D., Peloquin C.A., et al. Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis. Antimicrob Agents Chemother 50 (2006) 2621-2625
47. Ogata K., Linzer B.A., Zuberi R.I., Ganz T., Lehrer R.I., and Catanzaro A. Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare. Infect Immun 60 (1992) 4720-4725
48. Pazgier M., Hoover D.M., Yang D., Lu W., and Lubkowski J. Human beta-defensins. Cell Mol Life Sci 63 (2006) 1294-1313
49. Peschel A., Jack R.W., Otto M., Collins L.V., Staubitz P., Nicholson G., et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 193 (2001) 1067-1076
50. Porter E.M., Liu L., Oren A., Anton P.A., and Ganz T. Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun 65 (1997) 2389-2395
51. Raj P.A., and Dentino A.R. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett 206 (2002) 9-18
52. Rastogi N., Labrousse V., Goh K.S., and De Sousa J.P. Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. Antimicrob Agents Chemother 35 (1991) 2473-2480
53. Rivas-Santiago B., Schwander S.K., Sarabia C., Diamond G., Klein-Patel M.E., Hernandez-Pando R., et al. Human β-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect Immun 73 (2005) 4505-4511
54. Rodriguez-Jimenez F.J., Krause A., Schulz S., Forssmann W.G., Conejo-Garcia J.R., Schreeb R., et al. Distribution of new human beta-defensin genes clustered on chromosome 20 in functionally different segments of epididymis. Genomics 81 (2003) 175-183
55. Samad A, Sultana Y, Akhter MS, Aqil M. Treatment of tuberculosis: use of active pharmaceuticals. Recent Patent Anti-Infect Drug Disc 2008;3:34-44.
56. Schröder J.M., and Harder J. Human beta-defensin-2. Int J Biochem Cell Biol 31 (1999) 645-651
57. Schutte B.C., Mitros J.P., Bartlett J.A., Walters J., Jia H.P., Welsh M.J., et al. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA 99 (2002) 2129-2133
58. Schutte B.C., and McCray Jr. P.B. β-Defensins in lung host defense. Annu Rev Physiol 64 (2002) 709-748
59. Sharma S., Verma I., and Khuller G.K. Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis. Antimicrob Agents Chemother 45 (2001) 639-640
60. 37Ra. Arch Microbiol 171 (1999) 338-342
61. 37Rv: in vitro and ex vivo study. Eur Respir J 16 (2000) 112-117
62. Silva M.T., Silva M.N., and Appelberg R. Neutrophil-macrophage cooperation in the host defence against mycobacterial infections. Microb Pathog 6 (1989) 369-380
63. Singh P.K., Jia H.P., Wiles K., Hesselberth J., Liu L., Conway B.A., et al. Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci USA 95 (1998) 14961-14966
64. Sorensen O., Arnljots K., Cowland J.B., Bainton D.F., and Borregaard N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90 (1997) 2796-2803
65. Sparkes R.S., Kronenberg M., Heinzmann C., Daher K.A., Klisak I., Ganz T., et al. Assignment of defensin gene(s) to human chromosome 8p23. Genomics 5 (1989) 240-244
66. Tang Y.Q., and Selsted M.E. Characterization of the disulfide motif in BNBD-12, an antimicrobial beta-defensin peptide from bovine neutrophils. J Biol Chem 268 (1993) 6649-6653
67. Tomioka H., Sato K., Shimizu T., and Sano C. Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs. J Infect 44 (2002) 160-165
68. Tsutsumi-Ishii Y., and Nagaoka I. Modulation of human β-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J Immunol 170 (2003) 4226-4236
69. World Health Organization. Anti-tuberculosis drug resistance in the world. Prevalence and trends. WHO/CDS/TB/2000/.278. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Report 2. Geneva, Switzerland: World Health Organization; 2000.
70. World Health Organization. Guidelines for the management of multidrug tuberculosis (2006), World Health Organization, Geneva
71. World Health Organization. WHO report 2007: global tuberculosis control, surveillance, planning, financing. Geneva: WHO; 2007. 277 pp.
72. Yadava P., Zhang C., Sun J., and Hughes J.A. Antimicrobial activities of human beta-defensins against Bacillus species. Int J Antimicrob Agents 28 (2006) 132-137
73. Yang D., Chertov O., and Oppenheim J.J. The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cell Mol Life Sci 58 (2001) 978-989
74. Yew W.W., and Leung C.C. Update in tuberculosis 2007. Am J Respir Crit Care Med 177 (2008) 479-485
75. Zanetti M., Gennaro R., and Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374 (1995) 1-5
76. Zhu B.D., Feng Y., Huang N., Wu Q., and Wang B.Y. Mycobacterium bovis Bacille Calmette-Guérin (BCG) enhances human beta-defensin-1 gene transcription in human pulmonary gland epithelial cells. Acta Pharmacol Sin 24 (2003) 907-912